Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility

Alimentary Pharmacology and Therapeutics

Volumn 33, Issue 12, 2011, Pages 1370-1377

  Boecxstaens, V ^a   Bisschops, R ^a   Blondeau, K ^a   Vos, R ^a   Scarpellini, E ^a   De Wulf, D ^a   Tack, J ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; PLACEBO; SODIUM CHLORIDE; SUMATRIPTAN;

ACIDITY; ADULT; ARTICLE; BILE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GASTRIC PH MONITORING; HUMAN; HUMAN EXPERIMENT; LOWER ESOPHAGUS SPHINCTER; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; STOMACH MOTILITY; STOMACH PH;

ADULT; BILE; ERYTHROMYCIN; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRIC ACID; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; PLACEBOS; POSTPRANDIAL PERIOD; SUMATRIPTAN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79956077662     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04664.x     Document Type: Article

References (31)

1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R,. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20.
2. Locke GR III, Talley NG, Fett SL, Zinsmmeister AR, Melton LJ III,. Prevalence and clinical spectrum of gastroesophageal reflux: a population-bases study in Olmsted County. Gastroenterology 1997; 112: 1448-56. (Pubitemid 27181367)
3. Tack J,. Review article: the role of bile and pepsin in the pathophysiology and treatment of gastroesophageal reflux disease. Aliment Pharmacol Ther 2006; 24 (Suppl): 10-6. (Pubitemid 44267778)
4. Bardhan KD,. The role of proton pomp inhibitors in the treatment of gastroesophageal reflux disease. Aliment Pharmacol Ther 1995; 9 (suppl1): 15-25.
5. Tack J, Koek G, Demedts I, Sifrim D, Janssens J,. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux or both? Am J Gastroenterol 2004; 99: 981-8. (Pubitemid 38917796)
6. Tack J, Blondeau K,. Weakly acidic reflux. Dig Dis 2009; 27: 58-61.
7. Blondeau K, Tack J,. Pro: impedance testing is useful in the management of GERD. Am J Gastroenterol 2009; 104: 2664-6.
8. Vaezi MF, Richter JE,. Role of acid and duodenogastroesophageal reflux disease. Gastroenterology 1996; 111: 1992-9.
9. Koek GH, Tack J, Sifrim D, Lerut T, Janssens J,. The role of acid and duodenal gastroesophageal reflux in symptomatic GERD. Am J Gastroenterol 2001; 96: 2033-40. (Pubitemid 32660894)
10. Koek GH, Sifrim D, Lerut T, Janssens J, Tack J,. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus. Gut 2008; 57: 1056-64.
11. Fletcher J, Wirz A, Young J, Vallance R, McColl KE,. Unbuffered highly acidic gastric juice exists at the gastro-oesophageal junction after a meal. Gastroenterology 2001; 121: 775-83. (Pubitemid 32959387)
12. Fletcher J, Wirz A, Henry E, McColl KE,. Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux. Gut 2004; 53: 168-73. (Pubitemid 38125501)
13. Goetze O, Treier R, Fox M, et al. The effect of gastric secretion on gastric physiology and emptying in the fasted and fed state assessed by magnetic resonance imaging. Neurogastroenterol Motil 2009; 21: 725-42.
14. Beaumont H, Bennink RJ, de Jong J, Boeckxstaens GE,. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut 2010; 59: 441-51.
15. Annese V, Janssens J, Vantrappen G, et al. Erythromycin accelerates gastric emptying in man by inducing powerful antral contractions and an improved gastroduodenal coordination. Gastroenterology 1992; 102: 823-8.
16. Piessevaux H, Tack J, Wilmer A, Coulie B, Geubel A, Janssens J,. Perception of changes in wall tension of the proximal stomach in man. Gut 2001; 49: 203-8. (Pubitemid 32675112)
17. Coulie B, Tack J, Maes B, Ghoos Y, De Roo M, Janssens J,. Sumatriptan, a selective 5-HT1 receptor agonist, induces a lag phase for gastric emptying of liquids in man. Am J Physiol 1997; 272: G902-8.
18. Tack J, Coulie B, Wilmer A, Andrioli A, Janssens J,. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distention on man. Gut 2000; 46: 468-73. (Pubitemid 30305809)
19. Caldwell MTP, Byrnet PJ, Brazil N, et al. An ambulatory bile reflux monitoring system: an in vitro appraisal. Physiol Meas 1994; 15: 57-65. (Pubitemid 24063826)
20. Cuomo R, Koek G, Sifrim D, Janssens J, Tack J,. Analysis of ambulatory duodenogastroesophageal reflux monitoring. Dig Dis Sci 2000; 45: 2463-9. (Pubitemid 32198653)
21. Holloway RH, Kocyan P, Dent J,. Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux. Dig Dis Sci 1991; 36: 1034-9.
22. Cool M, Poelmans J, Feenstra L, Tack J,. Characteristics and clinical relevance of proximal esophageal pH monitoring. Am J Gastroenterol 2004; 99: 2317-23. (Pubitemid 40039359)
23. Koek GH, Vos R, Sifrim D, Cuomo R, Janssens J, Tack J,. Mechanisms underlying duodeno-gastric reflux in man. Neurogastroenterol Motil 2005; 17: 191-9. (Pubitemid 40476679)
24. Kamiya T, Adachi H, Hirako M, et al. Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease. J Gastroenterol 2009; 44: 183-9.
25. Bechi P, Pucciani F, Baldini F, et al. Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique. Dig Dis Sci 1993; 38: 1297-306. (Pubitemid 23242244)
26. Tack J, Bisschops R, Koek G, Sifrim D, Lerut T, Janssens J,. Dietary restrictions during ambulatory monitoring of duodenogastroesophageal reflux. Dig Dis Sci 2003; 48: 1213-20. (Pubitemid 36793896)
27. Janssens J, Peeters TL, Vantrappen G, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med 1990; 322: 1028-31. (Pubitemid 20146660)
28. Tack J, Janssens J, Vantrappen G, et al. Dose-related effect of erythromycin on gastroduodenal motility and plasma motilin levels. Studies in healthy volunteers and in patients with diabetic gastroparesis. Gastroenterology 1992; 103: 72-9.
29. Chaussade S, Michopoulos S, Sogni P, Guerre J, Couturier D,. Motilin agonist erythromycin increases human lower esophageal sphincter pressure by stimulation of cholinergic nerves. Dig Dis Sci 1994; 39: 381-4. (Pubitemid 24073615)
30. Tack J, Coulie B, Wilmer A, Peeters T, Janssens J,. Actions of the 5-hydroxytryptamine-1 receptor agonist sumatriptan on interdigestive gastrointestinal motility in man. Gut 1998; 42: 36-41. (Pubitemid 28228385)
31. Sifrim D, Holloway D, Tack J, et al. Effect of sumatriptan, a 5-HT1 agonist, on the frequency of transient lower esophageal sphincter relaxations and gastro-oesophageal reflux in healthy subjects. Am J Gastroenterol 1999; 94: 3158-64.